GILD Competitors & Alternatives
Compare Gilead Sciences Inc with similar stocks in the same industry
Drug Manufacturers - General
GILD
Main Stock$146.64
Tradestie Score
49
Market Cap
$137.92B
Revenue Growth
0.1%
Analyst Upside
+7.3%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVO
Novo-Nordisk A/S
|
$45.16
|
$262.92B | 11.4 | 48 | Compare |
|
AZN
AstraZeneca PLC
|
$160.04
|
$261.56B | 24.3 | 46 | Compare |
|
NVS
Novartis AG
|
$137.70
|
$254.99B | 24.2 | 42 | Compare |
|
MRK
Merck & Co., Inc.
|
$148.46
|
$225.13B | 120.3 | 47 | Compare |
|
AMGN
Amgen Inc
|
$393.17
|
$160.70B | 27.2 | 40 | Compare |
|
PFE
Pfizer Inc.
|
$27.79
|
$154.70B | 37.4 | 42 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$43.16
|
$121.27B | 23.5 | 39 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$64.69
|
$96.54B | 14.7 | 36 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$48.54
|
$91.59B | 15.7 | 35 | Compare |
|
REGN
Regeneron Pharmaceuticals Inc
|
$810.31
|
$63.59B | 20.5 | 43 | Compare |
More GILD Analysis
Data updated: Sep 09, 2026 | Industry: Drug Manufacturers - General (SIC 2836)
17 stocks in this industry